SEC Form 4: Buckle Isabelle converted options into 438 units of Ordinary Shares, increasing direct ownership by 21,900% to 440 units
$QTNT
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Quotient Ltd [ QTNT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 01/31/2023 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
|||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Ordinary Shares | 01/31/2023 | M | 438 | A | (1) | 440 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Ordinary Share Option (Right to Buy) | $192.4 | (2) | 09/01/2030 | Ordinary Shares | 519 | 519 | D | ||||||||
| Ordinary Share Option (Right to Buy) | $192.4 | (3) | 09/01/2030 | Ordinary Shares | 54 | 54 | D | ||||||||
| Ordinary Share Option (Right to Buy) | $182 | (4) | 10/31/2030 | Ordinary Shares | 340 | 340 | D | ||||||||
| Ordinary Share Option (Right to Buy) | $101.2 | (5) | 10/31/2031 | Ordinary Shares | 601 | 601 | D | ||||||||
| Restricted Stock Units | (1) | 01/31/2023 | M | 438 | (6) | (6) | Ordinary Shares | 438 | $0.00 | 1,312 | D | ||||
| Ordinary Share Option (Right to Buy) | $5.2 | (7) | 10/31/2032 | Ordinary Shares | 1,000 | 1,000 | D | ||||||||
| Explanation of Responses: |
| 1. Restricted Stock Units convert into ordinary shares on a one-for-one basis. |
| 2. 173 options vested on September 1, 2022 and remain exercisable, and the remaining 173 options will vest on September 2, 2023. |
| 3. All 54 options have vested and remain exercisable. |
| 4. All 340 options have vested and remain exercisable. |
| 5. All 601 options have vested and remain exercisable. |
| 6. On October 31, 2022, the Reporting Person was granted 1,750 restricted stock units, of which 438 have vested and have converted into ordinary shares. The remaining 1,312 restricted stock units will vest in three equal installments on April 30, 2023, July 31, 2023 and October 31, 2023. |
| 7. The options vest and become exercisable on October 31, 2023. |
| Remarks: |
| /s/ Isabelle Buckle | 02/02/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||